What is Ecolab, Inc.'s earnings per share (EPS)?

Ecolab, Inc. (ECL) reported diluted earnings per share of $7.28 for fiscal year 2025. This represents a -1.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ecolab, Inc. (ECL) Financials

ECL

Trailing 12 months to June 30, 2026

Revenue $16.8B +7.1% YoY

Net Income $2.1B YoY not available

EPS (Diluted) $7.45 -0.5% YoY

Free Cash Flow $1.9B +19.1% YoY

Market Cap $79.0B as of Oct 10, 2026

Price / Sales 4.7x on $16.8B revenue, trailing 12 months to June 30, 2026

Price / Earnings 37.3x on $2.1B net income, trailing 12 months to June 30, 2026

Price / Book 7.9x on $10.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ECL SEC filings page.

Ecolab, Inc. (ECL) reported $16.8B in revenue over the twelve months to Jun 30, 2026, up 7.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ECL FY2025 2026-10-03

Ecolab’s profit step-up has held near its peak, while heavier investment and tighter working capital make cash conversion central.

Gross margin widened from 40.2% in FY2023 to 44.5% in FY2025, showing that the company’s product economics improved across the period. Yet operating margin slipped from 17.8% in FY2024 to 17.0% in FY2025 even as gross margin rose, indicating that costs below gross profit absorbed part of the improvement rather than letting it flow fully to operating earnings.

The earnings-to-cash bridge is favorable but investment-heavy: FY2025 operating cash flow was $3.0B against net income of $2.1B, so reported profit converted into more cash before reinvestment. Capital expenditures reached $1.0B, leaving free cash flow of $1.9B; cash generation therefore carries a sizable asset-reinvestment claim.

The balance sheet presents a split signal: short-term flexibility narrowed as the current ratio fell from 1.3x in FY2023 to 1.1x in FY2025, with current liabilities nearly matching current assets. At the same time, leverage declined from 0.9x to 0.8x over the same span, indicating less near-term cushion but a lighter debt burden relative to equity.

Financial Health Signals

Financial Health Score 54/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ecolab, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Ecolab, Inc. has an operating margin of 17.0%, meaning the company retains $17 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is down from 17.8% the prior year.

Growth

Ecolab, Inc.'s revenue grew a modest 2.2% year-over-year to $16.1B. This slow but positive growth earns a score of 40/100.

Leverage

Ecolab, Inc. has a moderate D/E ratio of 0.75. This balance of debt and equity financing earns a leverage score of 34/100.

Liquidity

Ecolab, Inc.'s current ratio of 1.08 is below the typical benchmark, resulting in a score of 22/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Ecolab, Inc. converts 11.8% of revenue into free cash flow ($1.9B). This strong cash generation earns a score of 70/100.

Returns

Ecolab, Inc. earns a strong 21.2% return on equity (ROE), meaning it generates $21 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is down from 24.1% the prior year.

Altman Z-Score Safe

4.95

Ecolab, Inc. scores 4.95, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($79.0B) relative to total liabilities ($14.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Ecolab, Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.42x

For every $1 of reported earnings, Ecolab, Inc. generates $1.42 in operating cash flow ($3.0B OCF vs $2.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

8.94x

Ecolab, Inc. earns $8.94 in operating income for every $1 of interest expense ($2.7B vs $306.2M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.4B

YoY+9.7%

QoQ+8.6%

5Y CAGR+6.9%

10Y CAGR+2.9%

Ecolab, Inc. generated $4.4B in revenue in Q2 2026. This represents an increase of 9.7% from the same quarter a year earlier. Against the prior quarter it is up 8.6%.

EBITDA

$1.0B

YoY+7.9%

QoQ+16.0%

5Y CAGR+9.5%

10Y CAGR+5.1%

Ecolab, Inc.'s EBITDA was $1.0B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.9% from the same quarter a year earlier. Against the prior quarter it is up 16.0%.

Net Income

$534.9M

YoY+2.0%

QoQ+23.6%

Ecolab, Inc. reported $534.9M in net income in Q2 2026. This represents an increase of 2.0% from the same quarter a year earlier. Against the prior quarter it is up 23.6%.

EPS (Diluted)

$1.90

YoY+3.3%

QoQ+25.0%

5Y CAGR+12.0%

10Y CAGR+8.1%

Ecolab, Inc. earned $1.90 per diluted share (EPS) in Q2 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is up 25.0%.

Cash & Balance Sheet

Free Cash Flow

$489.4M

YoY+0.9%

QoQ+402.5%

5Y CAGR+6.4%

10Y CAGR+7.4%

Ecolab, Inc. generated $489.4M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 0.9% from the same quarter a year earlier. Against the prior quarter it is up 402.5%.

Cash & Debt

$5.1B

YoY+167.3%

QoQ+887.9%

5Y CAGR+29.6%

10Y CAGR+40.8%

Ecolab, Inc. held $5.1B in cash against $11.9B in long-term debt as of Q2 2026.

Dividends Per Share

$0.73

YoY+12.3%

QoQ0.0%

5Y CAGR+8.7%

10Y CAGR+7.6%

Ecolab, Inc. paid $0.73 per share in dividends in Q2 2026. This represents an increase of 12.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

280M

YoY-1.2%

QoQ-0.4%

5Y CAGR-0.4%

10Y CAGR-0.4%

Ecolab, Inc. had 280M shares outstanding in Q2 2026. This represents a decrease of 1.2% from the same quarter a year earlier. Against the prior quarter it is down 0.4%.

Margins & Returns

Gross Margin

44.1%

YoY-0.7pp

QoQ+0.5pp

5Y change+2.4pp

10Y change-2.1pp

Ecolab, Inc.'s gross margin was 44.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Operating Margin

17.2%

YoY-0.5pp

QoQ+1.9pp

5Y change+3.0pp

10Y change+4.7pp

Ecolab, Inc.'s operating margin was 17.2% in Q2 2026, reflecting core business profitability. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.

Net Margin

12.1%

YoY-0.9pp

QoQ+1.5pp

Ecolab, Inc.'s net profit margin was 12.1% in Q2 2026, showing the share of revenue converted to profit. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Return on Equity

5.3%

YoY-0.3pp

QoQ+1.0pp

Ecolab, Inc.'s ROE was 5.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.

Capital Allocation

Share Buybacks

$324.9M

YoY+614.1%

QoQ-5.7%

5Y CAGR+105.8%

10Y CAGR+2.7%

Ecolab, Inc. spent $324.9M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 614.1% from the same quarter a year earlier. Against the prior quarter it is down 5.7%.

Capital Expenditures

$240.1M

YoY+10.8%

QoQ-31.1%

5Y CAGR+10.8%

10Y CAGR+3.9%

Ecolab, Inc. invested $240.1M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 10.8% from the same quarter a year earlier. Against the prior quarter it is down 31.1%.

R&D Spending

Not reported for Q2 2026.

ECL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ECL quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$16.8B	$16.1B+2.2%	$15.7B+2.7%	$15.3B+8.0%	$14.2B+11.4%	$12.7B+8.0%	$11.8B-6.1%	$12.6B+2.8%	$12.2B+6.0%	$11.5B-12.3%	$13.2B-2.9%	$13.5B-5.1%	$14.3B+7.7%	$13.3B+11.9%	$11.8B+74.1%	$6.8B
Cost of Revenue	$9.4B	$8.9B+0.3%	$8.9B-2.8%	$9.2B+3.7%	$8.8B+16.0%	$7.6B+10.3%	$6.9B-2.0%	$7.0B+2.5%	$6.9B+7.2%	$6.4B-14.9%	$7.5B+4.3%	$7.2B-5.9%	$7.7B+7.2%	$7.2B+12.1%	$6.4B+83.7%	$3.5B
Gross Profit	$7.4B	$7.2B+4.5%	$6.8B+11.0%	$6.2B+15.1%	$5.4B+4.7%	$5.1B+4.8%	$4.9B-11.5%	$5.5B+3.2%	$5.3B+4.5%	$5.1B-8.9%	$5.6B-11.1%	$6.3B-4.2%	$6.6B+8.4%	$6.1B+11.7%	$5.5B+64.1%	$3.3B
R&D Expenses	N/A	$202.0M-2.4%	$207.0M+7.8%	$192.0M+1.1%	$190.0M+2.2%	$186.0M+0.5%	$185.0M-2.6%	$190.0M-1.6%	$193.0M+9.0%	$177.0M-6.3%	$189.0M-1.0%	$191.0M-3.0%	$197.0M+4.8%	$188.0M+2.7%	$183.0M+90.6%	$96.0M
SG&A Expenses	$4.4B	$4.3B+0.7%	$4.2B+4.1%	$4.1B+11.2%	$3.7B+7.0%	$3.4B+3.2%	$3.3B-6.8%	$3.6B+1.3%	$3.5B+4.2%	$3.4B-9.3%	$3.7B-14.7%	$4.3B-5.1%	$4.6B+5.0%	$4.4B+8.5%	$4.0B+64.8%	$2.4B
Operating Income	$2.9B	$2.7B-2.3%	$2.8B+40.7%	$2.0B+27.5%	$1.6B-2.3%	$1.6B+14.5%	$1.4B-24.4%	$1.8B+6.8%	$1.7B-1.1%	$1.7B-6.6%	$1.9B+19.8%	$1.6B-20.1%	$2.0B+25.3%	$1.6B+21.0%	$1.3B+71.0%	$753.8M
EBITDA	N/A	$3.7B-0.6%	$3.7B+28.2%	$2.9B+16.6%	$2.5B+2.4%	$2.4B+10.5%	$2.2B-15.7%	$2.6B+6.6%	$2.5B+1.0%	$2.4B-10.6%	$2.7B+12.8%	$2.4B-14.4%	$2.8B+19.0%	$2.4B+18.2%	$2.0B+74.3%	$1.1B
Interest Expense	$329.7M	$306.2M-10.0%	$340.3M-2.5%	$348.9M+38.4%	$252.1M+9.3%	$230.6M-24.3%	$304.8M+42.2%	$214.4M-9.0%	$235.5M-13.5%	$272.2M-4.6%	$285.4M+12.5%	$253.7M-5.3%	$268.0M-1.8%	$272.8M-4.5%	$285.6M+247.9%	$82.1M
Income Tax	$496.1M	$454.6M+3.5%	$439.3M+21.2%	$362.5M+54.6%	$234.5M-13.2%	$270.2M+53.0%	$176.6M-38.8%	$288.6M-10.1%	$321.2M+69.2%	$189.8M-52.9%	$402.9M+34.1%	$300.5M-36.9%	$476.2M+46.7%	$324.7M+4.3%	$311.3M+43.9%	$216.3M
Net Income	$2.1B	$2.1B-1.7%	$2.1B+53.9%	$1.4B+25.7%	$1.1B-3.4%	$1.1B+195.3%	-$1.2B-175.2%	$1.6B+9.4%	$1.4B-5.2%	$1.5B+21.8%	$1.2B+22.5%	$1.0B-16.8%	$1.2B+25.5%	$973.6M+38.8%	$701.3M+51.4%	$463.3M
EPS (Basic)	N/A	$7.33-1.3%	$7.43+54.1%	$4.82+25.8%	$3.83-3.0%	$3.95+194.0%	-$4.20-177.6%	$5.41+9.3%	$4.95-4.8%	$5.20+23.8%	$4.20+24.3%	$3.38-15.7%	$4.01+24.1%	$3.23+34.0%	$2.41+23.6%	$1.95
EPS (Diluted)	$7.45	$7.28-1.2%	$7.37+53.9%	$4.79+25.7%	$3.81-2.6%	$3.91+194.2%	-$4.15-177.9%	$5.33+9.2%	$4.88-4.7%	$5.12+23.7%	$4.14+24.7%	$3.32-15.5%	$3.93+24.4%	$3.16+34.5%	$2.35+23.0%	$1.91
Diluted Shares (Avg)	N/A	285M-0.5%	287M0.0%	287M0.0%	287M-0.9%	289M-0.4%	290M-0.8%	293M-0.1%	293M-0.4%	294M-0.9%	297M-1.6%	301M-1.5%	306M0.0%	306M+2.3%	299M+23.5%	242M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$4.4B+9.7%	$4.1B+10.0%	$4.2B+4.8%	$4.2B+4.2%	$4.0B+1.0%	$3.7B-1.5%	$4.0B+1.7%	$4.0B+1.0%
Cost of Revenue	$2.5B+11.1%	$2.3B+11.4%	$2.3B+3.5%	$2.3B+1.7%	$2.2B-0.8%	$2.1B-3.2%	$2.3B-0.7%	$2.3B-3.0%
Gross Profit	$1.9B+8.0%	$1.8B+8.3%	$1.8B+6.4%	$1.9B+7.4%	$1.8B+3.3%	$1.6B+0.7%	$1.7B+5.0%	$1.7B+6.7%
SG&A Expenses	$1.1B+6.9%	$1.1B+5.0%	$1.1B+1.0%	$1.1B+5.3%	$1.1B-0.7%	$1.1B-2.6%	$1.1B+1.5%	$1.0B0.0%
Operating Income	$757.9M+6.7%	$622.0M+12.0%	$712.0M+22.2%	$760.2M-27.2%	$710.1M+8.1%	$555.3M+7.2%	$582.8M-1.2%	$1.0B+84.6%
EBITDA	$1.0B+7.9%	$885.1M+11.8%	$968.3M+18.3%	$1.0B-21.4%	$951.8M+6.7%	$791.4M+5.1%	$818.8M-0.2%	$1.3B+60.3%
Interest Expense	$95.0M+24.7%	$77.3M+6.5%	$82.8M	$74.6M-13.7%	$76.2M-5.0%	$72.6M-23.2%	N/A	$86.4M-5.4%
Income Tax	$154.9M+17.9%	$121.5M+17.4%	$91.7M+67.3%	$128.0M-48.1%	$131.4M+37.3%	$103.5M+144.7%	$54.8M-56.7%	$246.5M+154.6%
Net Income	$534.9M+2.0%	$432.6M+7.5%	$563.9M	$585.0M-20.6%	$524.2M+6.8%	$402.5M-2.3%	N/A	$736.5M+82.3%
EPS (Basic)	$1.91+3.2%	$1.53+7.7%	$2.00+19.8%	$2.06-20.8%	$1.85+7.6%	$1.42-1.4%	$1.67+17.6%	$2.60+83.1%
EPS (Diluted)	$1.90+3.3%	$1.52+7.8%	$1.98+19.3%	$2.05-20.5%	$1.84+7.6%	$1.41-1.4%	$1.66+17.7%	$2.58+83.0%
Diluted Shares (Avg)	282M-1.1%	284M-0.6%	N/A	285M-0.2%	285M-0.6%	285M-0.9%	286M-0.5%	286M-0.3%

Not reported in any period shown, so not listed: R&D Expenses.

ECL Balance Sheet

ECL quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$24.7B+10.3%	$22.4B+2.5%	$21.8B+1.8%	$21.5B+1.2%	$21.2B+17.0%	$18.1B-13.1%	$20.9B+4.0%	$20.1B+0.6%	$20.0B+8.9%	$18.3B-1.7%	$18.6B-4.0%	$19.4B-1.1%	$19.6B+11.7%	$17.6B-3.4%	$18.2B
Current Assets	$6.0B-1.2%	$6.0B+6.8%	$5.6B+2.7%	$5.5B+17.2%	$4.7B-8.4%	$5.1B+6.0%	$4.8B+3.2%	$4.7B+1.8%	$4.6B+7.4%	$4.3B-3.8%	$4.4B-8.4%	$4.9B+3.3%	$4.7B-4.0%	$4.9B-9.3%	$5.4B
Cash & Equivalents	$646.2M-48.6%	$1.3B+36.7%	$919.5M+53.6%	$598.6M+66.3%	$359.9M-71.4%	$1.3B+960.8%	$118.8M+85.9%	$63.9M-69.8%	$211.4M-35.4%	$327.4M+252.8%	$92.8M-55.7%	$209.6M-38.2%	$339.2M-70.7%	$1.2B-37.2%	$1.8B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.5B+1.7%	$1.5B-2.2%	$1.5B-16.5%	$1.8B+20.2%	$1.5B+16.1%	$1.3B+18.8%	$1.1B-2.0%	$1.1B-23.7%	$1.4B+9.6%	$1.3B-5.0%	$1.4B-5.4%	$1.5B+11.0%	$1.3B+21.5%	$1.1B+1.7%	$1.1B
Accounts Receivable	$3.2B+13.4%	$2.9B+1.1%	$2.8B+5.0%	$2.7B+8.9%	$2.5B+9.0%	$2.3B-4.5%	$2.4B+7.8%	$2.2B-14.0%	$2.6B+9.8%	$2.3B-2.1%	$2.4B-9.0%	$2.6B+2.3%	$2.6B+15.4%	$2.2B+6.2%	$2.1B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$9.2B+16.7%	$7.9B-3.0%	$8.1B+1.7%	$8.0B-0.6%	$8.1B+34.2%	$6.0B+7.9%	$5.6B+3.2%	$5.4B-1.3%	$5.5B-14.4%	$6.4B-1.7%	$6.5B-3.4%	$6.7B-2.1%	$6.9B+15.9%	$5.9B+1.1%	$5.9B
Total Liabilities	$14.9B+9.5%	$13.6B-1.3%	$13.8B-3.0%	$14.2B+1.8%	$14.0B+17.0%	$11.9B-1.8%	$12.1B+1.0%	$12.0B-2.3%	$12.3B+8.4%	$11.4B-2.6%	$11.7B-3.2%	$12.0B-1.5%	$12.2B+7.1%	$11.4B-8.3%	$12.4B
Current Liabilities	$5.5B+15.5%	$4.8B+10.3%	$4.3B+3.2%	$4.2B+18.5%	$3.6B+21.2%	$2.9B-19.2%	$3.6B-1.5%	$3.7B+6.1%	$3.5B+15.1%	$3.0B-36.6%	$4.8B+9.1%	$4.4B+25.2%	$3.5B+14.3%	$3.1B-3.6%	$3.2B
Non-Current Liabilities	$9.4B+6.3%	$8.8B-6.6%	$9.4B-5.7%	$10.0B-3.9%	$10.4B+15.7%	$9.0B+5.6%	$8.5B+2.1%	$8.3B-5.7%	$8.8B+5.9%	$8.3B+20.9%	$6.9B-10.2%	$7.7B-12.1%	$8.7B+4.5%	$8.4B-9.9%	$9.3B
Long-Term Debt	$7.4B+6.0%	$6.9B-8.0%	$7.6B-6.5%	$8.1B-3.3%	$8.3B+25.2%	$6.7B+11.7%	$6.0B-5.2%	$6.3B-6.8%	$6.8B+10.0%	$6.1B+44.3%	$4.3B-12.0%	$4.8B-19.9%	$6.0B+5.4%	$5.7B-13.3%	$6.6B
Total Equity	$9.8B+11.6%	$8.8B+8.9%	$8.0B+11.2%	$7.2B+0.2%	$7.2B+17.2%	$6.2B-29.0%	$8.7B+8.5%	$8.0B+5.5%	$7.6B+9.9%	$6.9B-0.1%	$6.9B-5.5%	$7.3B-0.4%	$7.3B+20.9%	$6.1B+7.2%	$5.7B
Retained Earnings	$12.8B+11.4%	$11.5B+14.3%	$10.1B+8.1%	$9.3B+5.7%	$8.8B+6.9%	$8.2B-17.5%	$10.0B+12.2%	$8.9B+11.2%	$8.0B+14.9%	$7.0B+13.2%	$6.2B+10.9%	$5.6B+18.2%	$4.7B+16.9%	$4.0B+12.9%	$3.6B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$29.9B+26.1%	$25.0B+12.0%	$24.7B+10.3%	$23.9B+8.1%	$23.7B+10.6%	$22.4B+5.0%	$22.4B+2.5%	$22.1B+1.1%
Current Assets	$11.0B+55.7%	$6.0B-0.6%	$6.0B-1.2%	$7.1B+16.2%	$7.1B+23.0%	$6.1B+16.7%	$6.0B+6.8%	$6.1B+5.7%
Cash & Equivalents	$5.1B+167.3%	$519.8M-55.3%	$646.2M-48.6%	$2.0B+55.1%	$1.9B+400.2%	$1.2B+142.3%	$1.3B+36.7%	$1.3B+25.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.6B+4.7%	$1.6B+1.6%	$1.5B+1.7%	$1.5B-2.4%	$1.6B+4.2%	$1.5B-1.2%	$1.5B-2.2%	$1.6B+2.4%
Accounts Receivable	$3.5B+12.9%	$3.3B+14.8%	$3.2B+13.4%	$3.1B+8.0%	$3.1B+6.3%	$2.9B+2.5%	$2.9B+1.1%	$2.9B+2.1%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$9.4B+17.1%	$9.4B+20.0%	$9.2B+16.7%	$8.1B+2.7%	$8.0B+2.9%	$7.9B-3.0%	$7.9B-3.0%	$7.9B-2.5%
Total Liabilities	$19.8B+37.9%	$15.0B+11.5%	$14.9B+9.5%	$14.1B+4.6%	$14.4B+9.4%	$13.5B+3.0%	$13.6B-1.3%	$13.5B-3.6%
Current Liabilities	$6.0B+22.0%	$6.1B+32.3%	$5.5B+15.5%	$4.2B-11.1%	$4.9B+27.6%	$4.6B+24.5%	$4.8B+10.3%	$4.7B+2.4%
Non-Current Liabilities	$13.9B+46.2%	$8.9B+0.7%	$9.4B+6.3%	$10.0B+12.9%	$9.5B+1.8%	$8.9B-5.5%	$8.8B-6.6%	$8.8B-6.6%
Long-Term Debt	$11.9B+58.3%	$6.9B-1.1%	$7.4B+6.0%	$8.1B+15.5%	$7.5B-0.2%	$7.0B-7.1%	$6.9B-8.0%	$7.0B-6.8%
Total Equity	$10.1B+7.9%	$10.0B+12.7%	$9.8B+11.6%	$9.7B+13.7%	$9.3B+12.5%	$8.9B+8.2%	$8.8B+8.9%	$8.5B+9.6%
Retained Earnings	$13.4B+10.9%	$13.1B+11.3%	$12.8B+11.4%	$12.5B+11.1%	$12.1B+13.3%	$11.7B+13.7%	$11.5B+14.3%	$11.2B+14.2%

ECL Cash Flow Statement

ECL quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$3.1B	$3.0B+4.9%	$2.8B+16.7%	$2.4B+34.9%	$1.8B-13.3%	$2.1B+10.8%	$1.9B-23.2%	$2.4B+6.3%	$2.3B+8.9%	$2.1B+7.8%	$1.9B-3.0%	$2.0B+10.1%	$1.8B+16.4%	$1.6B+29.7%	$1.2B+75.5%	$685.5M
Depreciation & Amortization	N/A	$976.6M+4.3%	$935.9M+1.3%	$923.7M-1.6%	$938.5M+11.3%	$843.4M+3.7%	$813.3M+4.9%	$775.1M+6.3%	$728.9M+6.4%	$685.1M-19.5%	$851.0M-0.1%	$851.5M-1.3%	$863.1M+6.9%	$807.2M+13.0%	$714.5M+80.6%	$395.7M
Stock-Based Compensation	N/A	$136.6M+1.3%	$134.8M+41.7%	$95.1M+8.3%	$87.8M-1.9%	$89.5M+9.0%	$82.1M-2.3%	$84.0M-4.5%	$88.0M+2.9%	$85.5M-0.2%	$85.7M+9.6%	$78.2M+10.0%	$71.1M+2.2%	$69.6M+5.8%	$65.8M+64.9%	$39.9M
Capital Expenditures	$1.2B	$1.0B+5.4%	$994.5M+28.4%	$774.8M+8.7%	$712.8M+10.9%	$643.0M+31.5%	$489.0M-33.1%	$731.3M-6.1%	$778.7M-1.1%	$787.4M+4.0%	$756.8M-1.8%	$771.0M+3.0%	$748.7M+19.8%	$625.1M+8.8%	$574.5M+68.1%	$341.7M
Free Cash Flow	$1.9B	$1.9B+4.7%	$1.8B+11.1%	$1.6B+52.2%	$1.1B-24.2%	$1.4B+3.5%	$1.4B-18.8%	$1.7B+12.7%	$1.5B+15.0%	$1.3B+10.2%	$1.2B-3.7%	$1.2B+15.2%	$1.1B+14.1%	$934.7M+48.7%	$628.5M+82.8%	$343.8M
Investing Cash Flow	-$2.9B	-$2.7B-524.1%	-$433.8M+56.2%	-$990.5M-38.2%	-$716.8M+84.3%	-$4.6B-1004.9%	-$414.5M+65.4%	-$1.2B-16.4%	-$1.0B+40.4%	-$1.7B-123.2%	-$773.6M+15.5%	-$915.8M	N/A	N/A	N/A	N/A
Financing Cash Flow	$3.0B	-$853.3M+57.8%	-$2.0B-91.9%	-$1.1B-26.0%	-$837.3M-152.2%	$1.6B+569.0%	-$341.8M+74.7%	-$1.3B-15.1%	-$1.2B-124.4%	-$522.7M+39.8%	-$868.2M+24.6%	-$1.2B	N/A	N/A	N/A	N/A
Dividends Paid	$797.7M	$753.6M+13.4%	$664.3M+7.6%	$617.3M+2.4%	$602.8M+6.4%	$566.4M+1.0%	$560.8M+1.4%	$552.9M+11.7%	$494.8M+11.6%	$443.4M+3.7%	$427.5M+6.7%	$400.7M+16.3%	$344.4M+57.9%	$218.1M-28.9%	$306.8M+88.3%	$162.9M
Share Buybacks	$1.3B	$783.8M-20.5%	$986.5M+7100.7%	$13.7M-97.4%	$518.2M+386.1%	$106.6M-27.1%	$146.2M-58.7%	$353.7M-37.1%	$562.4M-6.3%	$600.3M-18.8%	$739.6M-2.1%	$755.1M+76.2%	$428.6M+39.3%	$307.6M+46.5%	$209.9M-69.6%	$690.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$729.5M+3.9%	$445.9M+20.7%	$1.1B+42.2%	$791.3M+0.6%	$701.8M+14.8%	$369.4M-43.1%	$766.7M-10.1%	$786.7M-0.1%
Depreciation & Amortization	$268.9M+11.3%	$263.1M+11.4%	$256.3M+8.6%	$242.5M+5.4%	$241.7M+2.9%	$236.1M+0.6%	$236.0M+2.3%	$230.1M+0.3%
Stock-Based Compensation	N/A	$40.3M-4.5%	N/A	N/A	N/A	$42.2M-10.2%	N/A	N/A
Capital Expenditures	$240.1M+10.8%	$348.5M+46.5%	$332.1M-7.7%	$261.6M+10.7%	$216.7M+10.1%	$237.9M+18.1%	$359.7M+37.0%	$236.4M+42.0%
Free Cash Flow	$489.4M+0.9%	$97.4M-25.9%	$758.0M+86.2%	$529.7M-3.7%	$485.1M+17.1%	$131.5M-70.6%	$407.0M-31.0%	$550.3M-11.4%
Investing Cash Flow	-$274.0M-22.1%	-$355.5M-58.7%	-$2.0B-215.3%	-$280.6M-143.9%	-$224.4M+8.2%	-$224.0M-11.4%	-$627.5M-80.1%	$639.1M+457.8%
Financing Cash Flow	$4.2B+1297.4%	-$225.8M+6.5%	-$431.6M-208.1%	-$477.4M+12.9%	$297.3M+166.6%	-$241.6M+72.8%	-$140.1M+76.1%	-$548.3M-273.0%
Dividends Paid	$208.2M+10.7%	$215.9M+12.4%	$189.2M+17.2%	$184.4M+13.7%	$188.0M+13.6%	$192.0M+9.6%	$161.4M+4.3%	$162.2M+5.3%
Share Buybacks	$324.9M+614.1%	$344.4M+124.1%	$409.2M+14514.3%	$175.4M-62.2%	$45.5M-85.9%	$153.7M-21.7%	$2.8M+40.0%	$464.3M+57937.5%

ECL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ECL quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	44.5%+1.0pp	43.5%+3.2pp	40.2%+2.5pp	37.8%-2.4pp	40.2%-1.2pp	41.4%-2.5pp	43.9%+0.2pp	43.8%-0.6pp	44.4%+1.6pp	42.7%-3.9pp	46.7%+0.4pp	46.2%+0.3pp	46.0%-0.1pp	46.1%-2.8pp	48.9%
Operating Margin	17.0%-0.8pp	17.8%+4.8pp	13.0%+2.0pp	11.0%-1.5pp	12.6%+0.7pp	11.8%-2.8pp	14.7%+0.6pp	14.1%-1.0pp	15.2%+0.9pp	14.2%+2.7pp	11.5%-2.2pp	13.7%+1.9pp	11.8%+0.9pp	10.9%-0.2pp	11.1%
Net Margin	12.9%-0.5pp	13.4%+4.5pp	9.0%+1.3pp	7.7%-1.2pp	8.9%+18.9pp	-10.1%-22.6pp	12.6%+0.8pp	11.8%-1.4pp	13.2%+3.7pp	9.5%+2.0pp	7.5%-1.0pp	8.6%+1.2pp	7.3%+1.4pp	5.9%-0.9pp	6.8%
Return on Equity	21.2%-2.9pp	24.1%+7.1pp	17.1%+2.0pp	15.1%-0.6pp	15.6%+34.9pp	-19.2%-37.4pp	18.1%+0.2pp	18.0%-2.0pp	20.0%+2.0pp	18.1%+3.3pp	14.7%-2.0pp	16.7%+3.5pp	13.3%+1.7pp	11.5%+3.4pp	8.2%
Return on Assets	8.4%-1.0pp	9.4%+3.2pp	6.3%+1.2pp	5.1%-0.2pp	5.3%+11.9pp	-6.5%-14.1pp	7.5%+0.4pp	7.2%-0.4pp	7.6%+0.8pp	6.8%+1.3pp	5.5%-0.8pp	6.3%+1.3pp	5.0%+1.0pp	4.0%+1.4pp	2.5%
Current Ratio	1.08-0.2x	1.260.0x	1.300.0x	1.300.0x	1.32-0.4x	1.75+0.4x	1.33+0.1x	1.27-0.1x	1.32-0.1x	1.42+0.5x	0.93-0.2x	1.11-0.2x	1.35-0.3x	1.60-0.1x	1.70
Debt-to-Equity	0.750.0x	0.79-0.1x	0.94-0.2x	1.120.0x	1.16+0.1x	1.08+0.4x	0.69-0.1x	0.79-0.1x	0.890.0x	0.89+0.3x	0.620.0x	0.66-0.2x	0.82-0.1x	0.94-0.2x	1.17
Asset Turnover	0.65-0.1x	0.700.0x	0.700.0x	0.66+0.1x	0.60-0.1x	0.650.0x	0.600.0x	0.610.0x	0.58-0.1x	0.720.0x	0.730.0x	0.74+0.1x	0.670.0x	0.67+0.3x	0.37
FCF Margin	11.8%+0.3pp	11.6%+0.9pp	10.7%+3.1pp	7.6%-3.6pp	11.1%-0.5pp	11.6%-1.8pp	13.5%+1.2pp	12.3%+0.9pp	11.3%+2.3pp	9.0%-0.1pp	9.1%+1.6pp	7.5%+0.4pp	7.0%+1.7pp	5.3%+0.3pp	5.1%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	44.1%-0.7pp	43.5%-0.7pp	44.0%+0.7pp	44.8%+1.4pp	44.8%+1.0pp	44.2%+1.0pp	43.4%+1.4pp	43.4%+2.3pp
Operating Margin	17.2%-0.5pp	15.3%+0.3pp	17.0%+2.4pp	18.3%-7.9pp	17.6%+1.2pp	15.0%+1.2pp	14.5%-0.4pp	26.1%+11.8pp
Net Margin	12.1%-0.9pp	10.6%-0.3pp	13.4%	14.1%-4.4pp	13.0%+0.7pp	10.9%-0.1pp	N/A	18.4%+8.2pp
Return on Equity	5.3%-0.3pp	4.3%-0.2pp	5.8%	6.0%-2.6pp	5.6%-0.3pp	4.5%-0.5pp	N/A	8.6%+3.4pp
Return on Assets	1.8%-0.4pp	1.7%-0.1pp	2.3%	2.5%-0.9pp	2.2%-0.1pp	1.8%-0.1pp	N/A	3.3%+1.5pp
Current Ratio	1.84+0.4x	0.99-0.3x	1.08-0.2x	1.70+0.4x	1.44-0.1x	1.32-0.1x	1.260.0x	1.300.0x
Debt-to-Equity	1.18+0.4x	0.69-0.1x	0.750.0x	0.830.0x	0.81-0.1x	0.79-0.1x	0.79-0.1x	0.82-0.1x
Asset Turnover	0.150.0x	0.160.0x	0.170.0x	0.170.0x	0.170.0x	0.170.0x	0.180.0x	0.180.0x
FCF Margin	11.1%-1.0pp	2.4%-1.2pp	18.1%+7.9pp	12.7%-1.0pp	12.0%+1.7pp	3.6%-8.4pp	10.2%-4.8pp	13.8%-1.9pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Ecolab, Inc. ECL	FY2025	$16.1B	$2.1B	12.9%	$79.0B	54/100
The Sherwin-Williams Company SHW	FY2025	$23.6B	$2.6B	10.9%	$77.5B	54/100
Air Products & Chemicals, Inc. APD	FY2025	$12.0B	-$394.5M	-3.3%	$62.6B	33/100
DuPont de Nemours, Inc. DD	FY2025	$6.8B	$88.0M	1.3%	$17.6B	38/100
PPG Industries, Inc. PPG	FY2025	$15.9B	$1.6B	9.9%	$23.1B	58/100
International Flavors & Fragrances Inc. IFF	FY2025	$10.9B	-$359.0M	-3.3%	$21.6B	27/100

Where Ecolab, Inc. Ranks

Frequently Asked Questions

What is Ecolab, Inc.'s annual revenue?

Ecolab, Inc. (ECL) reported $16.1B in total revenue for fiscal year 2025. This represents a 2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ecolab, Inc.'s revenue growing?

Ecolab, Inc. (ECL) revenue grew by 2.2% year-over-year, from $15.7B to $16.1B in fiscal year 2025.

Is Ecolab, Inc. profitable?

Yes, Ecolab, Inc. (ECL) reported a net income of $2.1B in fiscal year 2025, with a net profit margin of 12.9%.

What is Ecolab, Inc.'s EBITDA?

Ecolab, Inc. (ECL) had EBITDA of $3.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Ecolab, Inc. have?

As of fiscal year 2025, Ecolab, Inc. (ECL) had $646.2M in cash and equivalents against $7.4B in long-term debt.

What is Ecolab, Inc.'s gross margin?

Ecolab, Inc. (ECL) had a gross margin of 44.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ecolab, Inc.'s operating margin?

Ecolab, Inc. (ECL) had an operating margin of 17.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Ecolab, Inc.'s net profit margin?

Ecolab, Inc. (ECL) had a net profit margin of 12.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Ecolab, Inc. pay dividends?

Yes, Ecolab, Inc. (ECL) paid $2.68 per share in dividends during fiscal year 2025.

What is Ecolab, Inc.'s return on equity (ROE)?

Ecolab, Inc. (ECL) has a return on equity of 21.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ecolab, Inc.'s free cash flow?

Ecolab, Inc. (ECL) generated $1.9B in free cash flow during fiscal year 2025. This represents a 4.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ecolab, Inc.'s operating cash flow?

Ecolab, Inc. (ECL) generated $3.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ecolab, Inc.'s total assets?

Ecolab, Inc. (ECL) had $24.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ecolab, Inc.'s capital expenditures?

Ecolab, Inc. (ECL) invested $1.0B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Ecolab, Inc. spend on research and development?

Ecolab, Inc. (ECL) invested $202.0M in research and development during fiscal year 2025.

Does Ecolab, Inc. buy back shares?

Yes, Ecolab, Inc. (ECL) spent $783.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Ecolab, Inc. have outstanding?

Ecolab, Inc. (ECL) had 282M shares outstanding as of fiscal year 2025.

What is Ecolab, Inc.'s current ratio?

Ecolab, Inc. (ECL) had a current ratio of 1.08 as of fiscal year 2025, which is considered adequate.

What is Ecolab, Inc.'s debt-to-equity ratio?

Ecolab, Inc. (ECL) had a debt-to-equity ratio of 0.75 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ecolab, Inc.'s return on assets (ROA)?

Ecolab, Inc. (ECL) had a return on assets of 8.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ecolab, Inc.'s P/E ratio?

Ecolab, Inc. (ECL) trades at 37.3x earnings, its market capitalization divided by net income of $2.1B net income, trailing 12 months to June 30, 2026. The market capitalization is $79.0B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ecolab, Inc.'s price-to-sales ratio?

Ecolab, Inc. (ECL) trades at 4.7x sales, its market capitalization divided by revenue of $16.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $79.0B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ecolab, Inc.'s Altman Z-Score?

Ecolab, Inc. (ECL) has an Altman Z-Score of 4.95, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Ecolab, Inc.'s Piotroski F-Score?

Ecolab, Inc. (ECL) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ecolab, Inc.'s earnings high quality?

Ecolab, Inc. (ECL) has an earnings quality ratio of 1.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Ecolab, Inc. cover its interest payments?

Ecolab, Inc. (ECL) has an interest coverage ratio of 8.94x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Ecolab, Inc.?

Ecolab, Inc. (ECL) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.